Gardner Lewis Asset Management »

Terns Pharmaceuticals shares owned by Gardner Lewis Asset Management

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Gardner Lewis Asset Management from 13F filings

Historical chart of Gardner Lewis Asset Management investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Gardner Lewis Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Gardner Lewis Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.6M 50k 52.72

More positions owned by Gardner Lewis Asset Management

NVIDIA Corporation (NVDA)
Amicus Therapeutics (FOLD)
Sealed Air
Air Lease Corp
Tri Pointe Homes (TPH)
Ubs Group (UBS)
Arcellx (ACLX)
Boeing Company (BA)
Blue Foundry Bancorp
Apple (AAPL)
Citigroup (C)
MasterCard Incorporated (MA)
DigitalBridge Group (DBRG)
Alphabet Inc Class C cs (GOOG)
Amazon (AMZN)

View all positions for Gardner Lewis Asset Management

Top funds holding Terns Pharmaceuticals

BlackRock
Morgan Stanley
Adage Capital Partners GP
Vanguard Group
Vanguard Capital Management
venBio Select Advisor
Holocene Advisors
Balyasny Asset Management
Citadel Advisors
Millennium Management
HBK Investments
Lord, Abbett & Co
Ikarian Capital
Franklin Resources
Geode Capital Management

View all funds holding Terns Pharmaceuticals